Rituximab improves the control of pediatric nephrotic syndrome and reduces healthcare utilization
{{output}}
Background: Rituximab (RTX) is often used in children with nephrotic syndrome (NS), but there is lack of consensus on its dose among pediatric nephrologists. This study aimed to assess its efficacy in controlling NS and impact on... ...
